Refractory Hyperprolactinemia
Refractory Hyperprolactinemia is a clinical condition characterized by persistently elevated serum prolactin levels despite adequate treatment with dopamine agonists, distinguishing it from other forms of hyperprolactinemia by its resistance to standard pharmacologic intervention.
75
Publications
4.5K
Citations
352
Authors
155
Institutions
Publications per year
2017–2026
7
Parents
75
Antonella Di Sarno, Maria Luisa Landi, Paolo Cappabianca et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 257 citations
Medicine, Oncology, Pharmacology +13
Annamaria Colao, Antonella Di Sarno, Maria Luisa Landi et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 227 citations · Full text
Diagnosis and Management of Hyperprolactinemia
Omar Serri, Constance L. Chik, Ehud Ur et al. · Topics in Obstetrics & Gynecology · 2022 · 172 citations · Full text
1–5 of 75
352
5
h-index
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 352
155

University of Turin
Turin, Italy
3 h-index
23 publications
545 citations
Federico II University Hospital
Naples, Italy
3 h-index
5 publications
832 citations

University of Calgary
Calgary, Canada
2 h-index
6 publications
140 citations
Ben-Gurion University of the Negev
Beersheba, Israel
2 h-index
6 publications
150 citations

Tel Aviv University
Tel Aviv, Israel
2 h-index
13 publications
493 citations
Ansan University
Ansan-si, South Korea
2 h-index
3 publications
160 citations

Soroka Medical Center
Beersheba, Israel
2 h-index
6 publications
150 citations
Korea University
Seoul, South Korea
2 h-index
4 publications
255 citations
1–8 of 155
JCEM · 8 publications · 1K citations
8
h-index
8 publications · 320 citations
8
h-index
6 publications · 464 citations
6
h-index
6 publications · 186 citations
6
h-index
4 publications · 103 citations
4
h-index
1–5